Effect of Thymosin α1 on Immunoregulatory T Lymphocytes
The extensive work performed by A. L. Goldstein and co-workers has led to the isolation, chemical characterization, and biological and clinical applications of thymosins present in “fraction 5,” a partially purified extract from bovine thymus (Hooper et al., 1975). Fraction 5 consists of 40–50 peptides whose molecular weights range from 1000 to 15,000, as demonstrated by analytical Polyacrylamide gel electrophoresis and isoelectric focusing (Goldstein et al., 1977). Some of these peptides exhibit a wide range of biological activities in animal models (Goldstein, 1978). It has been established that there is no homology between the biologically active thymosin peptides and thymopoietin (Goldstein, 1975) or facteur thymique sérique (Bach and Dardenne, 1972). Among the several peptides present in fraction 5, α1 was the first to be purified, sequenced (Goldstein et al., 1977), and synthesized (Goldstein, 1978). It is a highly acidic molecule, consisting of 28 amino acid residues. Several tests performed both in vivo and in vitro have shown that α1 is 10–1000 times more active than fraction 5 in promoting T-cell differentiation. It has been found that in vivo administration of α1 enhances the lymphoid cell responses to mitogens as well as lymphotoxin production (Schulof and Goldstein, 1983). Results of α1 treatment in conjunction with intensive conventional chemotherapy show that growth of plasmacytoma MOPC-315 in Balb/c mice is reduced or prevented. Moreover, the surviving animals reject retransplanted tumor cells (Goldstein et al., 1983).
KeywordsSpleen Cell Young Mouse Helper Activity Nylon Wool Secondary Antibody Response
Unable to display preview. Download preview PDF.
- Ahmed, A., Wong, D. M., Thurman, G. B., Low, T. L. K., Goldstein, A. L., Sharkis, S. J., and Goldschneider, I., 1979, T-lymphocyte maturation: Cell surface markers and immune functions induced by T-lymphocyte cell-free products and thymosin polypeptides, Ann. N.Y. Acad. Sci. 332:81.PubMedCrossRefGoogle Scholar
- Cunningham, A. J., and Szenberg, A., 1968, Further improvements in plaque technique for detecting single antibody-forming cells, Immunology 14:559.Google Scholar
- Goldstein, A. L., Low, T. L. K., McAdoo, M., McClure, J., Thurman, G. B., Rossio, J., Lai, C-Y., Chang, D., Wang, S.-S., Harvey, C., Ramel, A. H., and Meienhofer, J., 1977, Thymosin α1. Isolation and sequence analysis of an immunologically active thymic polypeptide, Proc. Natl. Acad. Sci. USA 72:725.CrossRefGoogle Scholar
- Goldstein, A. L., Low, T. L. K., Zatz, M. M., Hall, N. R., and Naylor, T. H., 1983, Thymosins, Clin. Immunol. Allergy 3:119.Google Scholar
- Low, T. L. K., Thurman, G. B., Chincarini, C., McClure, J. E., Marshall, G. D., Hu, S.-K., and Goldstein, A. L., 1979, Current status of thymosin research: Evidence for the existence of a family of thymic factors that control T-cell maturation, Ann. N.Y. Acad. Sci. 332:33.PubMedCrossRefGoogle Scholar
- Schulof, R. S., and Goldstein, A. L., 1983, Clinical applications of thymosin and other thymic hormones, in: Recent Advances in Clinical Immunology, Vol. 3 (R. A. Thompson and N. R. Rose, eds.), pp. 243–286, Churchill Livingstone, New York.Google Scholar
- Wetzel, R., Heyneker, H. L., Goeddel, D. V., Jhurani, P., Shapiro, J., Crea, R., Low, T. L. K., McClure, J. E., Thurman, G. B., and Goldstein, A. L., 1980, Production of biologically active Nα-desacetyl thymosin α1 through expression of a chemically synthesized gene, Biochemistry 19:6096.PubMedCrossRefGoogle Scholar